Brief: 3Sbio Inc Says Approval Obtained For Inetetamab, First Innovative Anti-Her2 Monoclonal Antibody
19/06/2020 08:09
June 19 (Reuters) - 3SBio Inc 1530.HK :
* 3SBIO INC - APPROVAL OBTAINED FOR INETETAMAB, FIRST
INNOVATIVE
ANTI-HER2 MONOCLONAL ANTIBODY
* 3SBIO INC - GOT APPROVAL FROM NMPA OF PRC FOR INETETAMAB
Source text for Eikon: ID:nHKSbQS48t
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))